Long‐term dalteparin in pregnancy not associated with a decrease in bone mineral density: substudy of a randomized controlled trial
- 1 August 2007
- journal article
- research article
- Published by Elsevier in Journal of Thrombosis and Haemostasis
- Vol. 5 (8) , 1600-1606
- https://doi.org/10.1111/j.1538-7836.2007.02634.x
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Low-molecular-weight heparins for thromboprophylaxis and treatment of venous thromboembolism in pregnancy: a systematic review of safety and efficacyBlood, 2005
- Predictive Value of BMD for Hip and Other FracturesJournal of Bone and Mineral Research, 2005
- Antithrombotic prophylaxis for women with thrombophilia and pregnancy complicationsJournal of Thrombosis and Haemostasis, 2004
- A Detailed Assessment of Alterations in Bone Turnover, Calcium Homeostasis, and Bone Density in Normal PregnancyJournal of Bone and Mineral Research, 2000
- The Effect of Pregnancy on Bone Density and Bone TurnoverJournal of Bone and Mineral Research, 2000
- Universal Standardization of Bone Density Measurements: A Method with Optimal Properties for Calibration Among Several InstrumentsJournal of Bone and Mineral Research, 1997
- Pregnancy and lactation as risk factors for subsequent bone loss and osteoporosisJournal of Bone and Mineral Research, 1996
- Bone density changes during pregnancy and lactation in active women: a longitudinal studyBone and Mineral, 1991
- Prolonged heparin therapy in pregnancy causes bone demineralizationBJOG: An International Journal of Obstetrics and Gynaecology, 1983
- Long-Term Therapy with Subcutaneous Heparin during PregnancyGynecologic and Obstetric Investigation, 1982